This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations of James Nieman
Introduction
James Nieman is an accomplished inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of cytotoxic and anti-mitotic agents through his innovative work. His research focuses on the development of hemiasterlin analogs, which have important applications in medical science.
Latest Patents
James Nieman holds a patent for hemiasterlin analogs. This invention provides analogs of hemiasterlin, methods of synthesis of the analogs, and the use of the analogs as cytotoxic and anti-mitotic agents. His work in this area has the potential to impact cancer treatment and other medical applications.
Career Highlights
Nieman is affiliated with the University of British Columbia, where he continues to advance his research. His dedication to innovation in the field of medicinal chemistry is evident in his patent and ongoing projects.
Collaborations
James Nieman has collaborated with notable colleagues, including Raymond John Andersen and Michel Roberge. These partnerships enhance the scope and impact of his research.
Conclusion
James Nieman's contributions to the field of medicinal chemistry through his patent on hemiasterlin analogs demonstrate his commitment to innovation and research. His work has the potential to lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile